Ars Pharmaceuticals, Inc. ( (SPRY)) has released its Q3 earnings. Here is a breakdown of the information Ars Pharmaceuticals, Inc. presented to its investors. ARS Pharmaceuticals, Inc., a ...
In a report released today, Kostas Biliouris from BMO Capital assigned a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback